Zoetis (ZTS) Deferred Taxes (2012 - 2026)
Zoetis (ZTS) posted quarterly Deferred Taxes of $34.0 million for Q1 2026, up 142.86% year-over-year from $14.0 million in Q1 2025, and up 170.83% quarter-over-quarter from -$48.0 million in Q4 2025.
Zoetis (ZTS) Deferred Taxes (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Deferred Taxes for 15 consecutive years, with $34.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes rose 142.86% year-over-year to $34.0 million; the TTM figure through Mar 2026 stood at -$32.0 million (up 88.61% YoY), while the FY2025 annual figure was -$52.0 million, up 84.62% from the prior year.
- Deferred Taxes grew to $34.0 million in Q1 2026 per ZTS's latest filing, from -$48.0 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $34.0 million in Q1 2026 and bottomed at -$176.0 million in Q4 2022.
- Historically, Deferred Taxes has averaged -$41.4 million across 5 years, with a median of -$34.0 million in 2022.
- Annual changes were most pronounced in 2024 — Deferred Taxes tumbled 637.5% — and 2026, when it soared 142.86%.
- Zoetis' Deferred Taxes stood at -$176.0 million in 2022, then soared by 88.07% to -$21.0 million in 2023, then plunged by 623.81% to -$152.0 million in 2024, then jumped by 68.42% to -$48.0 million in 2025, then jumped by 170.83% to $34.0 million in 2026.
- Business Quant data shows ZTS's Deferred Taxes at $34.0 million in Q1 2026, -$48.0 million in Q4 2025, and -$16.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 9.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33.00 Mn |
| Mar 31, 2026 | 34.00 Mn |
| Dec 31, 2025 | -48.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | 14.00 Mn |
| Dec 31, 2024 | -152.00 Mn |
| Sep 30, 2024 | -42.00 Mn |
| Jun 30, 2024 | -101.00 Mn |
| Mar 31, 2024 | -43.00 Mn |
| Dec 31, 2023 | -21.00 Mn |
| Sep 30, 2023 | -14.00 Mn |
| Jun 30, 2023 | -34.00 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | -176.00 Mn |
| Sep 30, 2022 | -34.00 Mn |
| Jun 30, 2022 | -31.00 Mn |
| Mar 31, 2022 | -45.00 Mn |
| Dec 31, 2021 | 41.00 Mn |
| Sep 30, 2021 | -97.00 Mn |